Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis

Leonardo Pedrazza1, Talita Carneiro Brandão Pereira2, Ana Lucia Abujamra3

  • 1Laboratório de Pesquisa em Biofísica Celular e Inflamação, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Rio Grande do Sul, CEP 90619-900, Brazil. leopedrazza@gmail.com.

Abstract

Insights

Mesenchymal stem cells (MSCs) did not alter toll-like receptor (TLR) mRNA expression in mice with experimental sepsis. This study found no significant changes in TLR levels in various tissues after MSC treatment during sepsis.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) play a critical role in infectious diseases.
  • Mesenchymal stem cells (MSCs) possess immunomodulatory properties.

Purpose of the Study:

  • To investigate the effect of MSCs on the mRNA expression of TLRs in different tissues during experimental sepsis.
  • To evaluate the potential of MSCs to modulate the immune response in sepsis.

Main Methods:

  • Experimental sepsis model in C57BL/6 mice.
  • Three groups: control, untreated sepsis, and MSC-treated sepsis (1 × 10^6 cells/animal).
  • RT-qPCR analysis of TLR2, TLR3, TLR4, and TLR9 mRNA in lung, cortex, kidney, liver, and colon tissues after 12 hours.

Main Results:

  • Sepsis induction led to decreased TLR2 and TLR9 mRNA in the liver.
  • TLR3 mRNA expression was reduced in the lung and liver during sepsis.
  • No significant differences in TLR mRNA expression were observed between the untreated sepsis group and the MSC-treated sepsis group.

Conclusions:

  • In this experimental sepsis model, MSCs did not alter the mRNA expression of the evaluated toll-like receptors.
  • The immunomodulatory effects of MSCs, in this context, did not extend to modulating TLR expression in various tissues.